Skip to main content

Canada Newfoundland and Labrador facing renewed pressure to cover abortion pill Mifegymiso

Newfoundland and Labrador — the only province that does not provide at least partial coverage of the abortion pill — is under renewed pressure to do so.

Medical students and practitioners have written an open letter to the premier and health department asking for universal coverage of Mifegymiso, as well as supportive resources for physicians prescribing the drug.

The letter is a follow-up to a meeting between medical students and Health Minister John Haggie in March.

Story continues below advertisement

“The government has a responsibility to uphold everyone’s right to health and that includes access to abortion services that are comprehensive and accessible,” Maggie O’Dea, a medical student at Memorial University who met with Haggie, said Wednesday.

“We have such a rural and remote population that this is ultimately a huge potential win for the government to be able to provide that care and uphold their rights.”

The two-drug combination terminates pregnancies of up to nine weeks, as an alternative to surgical methods that are currently covered by the province.

Activists say the province has a unique need for the alternative abortion access.

Mifegymiso costs approximately $350, while a surgical abortion can cost as much as $1,500, not including travel costs to a clinic.

The province’s year-round abortion clinics are located in St. John’s, putting it out of financial reach for many low-income patients outside the capital.

“In (Atlantic Canada), it’s been definitely a place where access issues have been quite acute,” said Frederique Chabot of Action Canada for Sexual Health and Reproductive Rights.

Story continues below advertisement

Chabot’s organization has been monitoring the rollout of the drug across the country, and she said some provinces have been more effective than others at making the drug available.

B.C., Alberta, Ontario, Quebec, New Brunswick, and Nova Scotia have implemented universal coverage, but some of these provinces still have restrictions.

Chabot said the rallying from the medical community in Newfoundland and Labrador has been “quite wonderful to see.”

She hopes the provincial government will consider universal coverage along with a billing code, partnerships with medical colleges, and training and guidelines for practitioners, similar to what has been done in Alberta.

Robin Whitaker, an anthropology professor at Memorial University who has studied abortion access in Newfoundland and Labrador, said consideration of the circumstances of patients in remote communities is often overlooked since abortion has been de-criminalized in Canada.

“There’s no criminal law on abortion in this country and that’s a good thing, but politically sometimes there’s still some hesitation,” said Whitaker.

Story continues below advertisement

Rolanda Ryan, owner of Athena Health Clinic in St. John’s, said her clinic has performed 1,121 procedures since Mifegymiso rolled out at the end of January last year. Fifty of those used the drug — 38 of them in 2018 as word of its availability spread.

Ryan has worked with physicians in remote communities to prescribe the drug and says her clinic is happy to provide support to any practitioners — including access to the 24-hour phone line required after taking the pill.

She said she’s not sure whether the government will fully fund the pill given its financial situation, but hopes for at least a partial coverage plan to help low-income patients access the drug.

“I honestly don’t know what the outcome will be, but it has to be in such a way that people aren’t out of pocket, or that they’re minimally out of pocket,” said Ryan.

“It has to be so that nobody falls through the cracks because of the price tag of the pills.”

Every other province in Canada now offers some coverage of medical abortions using pills, with costs varying depending on a patient’s income, private health benefits and other factors, to full universal coverage for all residents.

Story continues below advertisement

“The universal access that was requested is like, gold standard, it’s kind of the best thing you could ask for,” said Ryan. “I don’t know what they’re ultimately gonna do, but ask for sky. Because why not?”

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter